Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and Bone Loss, Osteoclastic

staurosporine has been researched along with Bone Loss, Osteoclastic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battaglia, S; Blanchard, F; Brounais, B; Charrier, C; Chipoy, C; Heymann, D; Mori, K; Pilet, P; Rédini, F; Richards, CD1
Kawahara, I; Kinugawa, S; Kobayashi, Y; Koide, M; Mizoguchi, T; Muto, A; Nakamura, M; Ninomiya, T; Takahashi, N; Udagawa, N; Yasuda, H1
Lee, SK; Stern, PH1
Ma, ZJ; Yamaguchi, M1
Birkenhäger, JC; Bos, MP; Buurman, CJ; Pols, HA; Staal, A; van den Bemd, GJ; van Leeuwen, JP1

Other Studies

5 other study(ies) available for staurosporine and Bone Loss, Osteoclastic

ArticleYear
Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Sep-01, Volume: 14, Issue:17

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Cell Line, Tumor; Male; Oncostatin M; Osteosarcoma; Rats; Rats, Sprague-Dawley; Staurosporine

2008
Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Feb-15, Volume: 188, Issue:4

    Topics: Animals; B7-2 Antigen; Bone Resorption; CD11c Antigen; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dendritic Cells; Doxycycline; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minocycline; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; Phagocytosis; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction; STAT5 Transcription Factor; Staurosporine; Stem Cells

2012
Divergent effects of protein kinase C (PKC) inhibitors staurosporine and bisindolylmaleimide I (GF109203X) on bone resorption.
    Biochemical pharmacology, 2000, Oct-01, Volume: 60, Issue:7

    Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Calcium Radioisotopes; Drug Interactions; Enzyme Inhibitors; Indoles; Maleimides; Mice; Parathyroid Hormone; Protein Kinase C; Staurosporine

2000
Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro.
    Molecular and cellular biochemistry, 2001, Volume: 228, Issue:1-2

    Topics: Animals; Bone and Bones; Bone Marrow Cells; Bone Resorption; Bucladesine; Calcitonin; Calcium; Carcinogens; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Hemostatics; Male; Osteoclasts; Oxytocics; Peptide Fragments; Rats; Rats, Wistar; Staurosporine; Teriparatide; Tetradecanoylphorbol Acetate; Vitamin K 2

2001
Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
    The Journal of biological chemistry, 1992, Jun-25, Volume: 267, Issue:18

    Topics: Alkaloids; Animals; Bone Resorption; Calcitriol; Calcium; Cells, Cultured; Diglycerides; Hydroxyurea; Kinetics; Osteoblasts; Osteocalcin; Protein Kinase C; Rats; Receptors, Calcitriol; Receptors, Steroid; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Up-Regulation

1992